Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Profit up, EBITDA down for KPG, pegs hopes on US expansion to rake in the money
    • News

    Profit up, EBITDA down for KPG, pegs hopes on US expansion to rake in the money

    Kelly+Partners Group or KPG (ASX: KPG) is an accountants network, and they’ll have you know that they mean business. As the second half of FY23 begins, the Company has already released its audited financials for H1 FY23. KPG’s net profit is up 7.5% to $3.6 million, and it witnessed a 42.2% revenue growth to $44

    Read More
    Public
  • IRIS Metals gains $3.5 million funding for US lithium
    • News

    IRIS Metals gains $3.5 million funding for US lithium

    IRIS Metals (ASX: IR1) announced an investment of $1,500,000 from the Electrification and Decarbonization AIE LP Fund, managed by Waratah Capital Advisors. The placement saw 1,500,000 shares issued at $1 per share with a bonus 750,000 options with an exercise price of $1.50 two years from the date of issue. In addition to the $1,500,000

    Read More
    Public
  • Surge in allied health spending sees Healthia confirm a big boost in earnings guidance
    • News

    Surge in allied health spending sees Healthia confirm a big boost in earnings guidance

    After two years of lockdowns and pandemic health concerns, the sun is back shining on allied health company Healthia (ASX: HLA) which saw a big upswing in trading in November and December after many had been putting off non-urgent medical appointments during the pandemic.  The increased trading was witnessed across Healthia’s three disciplines – podiatry,

    Read More
    Public
  • BWX revises its FY23 forecast, following ASX suspension and eCommerce decline
    • News

    BWX revises its FY23 forecast, following ASX suspension and eCommerce decline

    Recovering from its rebellious phase—and after being disciplined by the ASX—global natural beauty and wellness company BWX Limited (ASX: BWX) is finally sobering up.  After its financial fiasco in 2022, the Company reported sales revenue of $38.1 million in Q2 FY23, significantly lower than its target. Of course, revenue was impacted by its dented revenue

    Read More
    Public
  • China revenue falls 66% as Bubs reports declining sales
    • News

    China revenue falls 66% as Bubs reports declining sales

    The infant formula market has more than doubled over the past decade. But not all companies have managed to keep up, thus making it a lucrative market for the few that have. Infant formula companies, like Bubs Australia (ASX: BUB), saw it as an opportunity to expand into global markets, even becoming one of the

    Read More
    Public
  • Skyfii delivered Impressive Q2 FY23 results with positive cash flow and new contract lineups
    • News

    Skyfii delivered Impressive Q2 FY23 results with positive cash flow and new contract lineups

    We’re just halfway through FY23, but it seems that the performance of Skyfii (ASX: SKF) has been a roaring success so far with several impressive achievements under its belt. After notably securing technology deployment contracts with McDonalds and major airports around the world not too long ago, the omnidata intelligence company proudly delivered positive cash

    Read More
    Public
  • «
  • ‹
  • 286
  • 287
  • 288
  • 289
  • 290
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.